These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 13661628)

  • 1. The comparative sensitivity of isolated coronary and systemic vessels to vasomotor agents.
    OPPELT WW; EDERSTROM HE
    Angiology; 1959 Jun; 10(3):153-7. PubMed ID: 13661628
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac drug responses and potassium shifts; studies on the interrelated effects of drugs on coronary flow, heart action and cardiac potassium movement. II.
    MELVILLE KI; KOROL B
    Am J Cardiol; 1958 Aug; 2(2):189-99. PubMed ID: 13559151
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacology of some new cycloöctylalkylamines. I. Vasopressor activity and the effect on the heart rate.
    KAHL RJ; JOHNSON WE; O'DAY DW
    J Am Pharm Assoc Am Pharm Assoc; 1958 Jun; 47(6):446-50. PubMed ID: 13549294
    [No Abstract]   [Full Text] [Related]  

  • 4. Regional differences in response of terminal vascular bed to vasoactive agents.
    ZWEIFACH BW; METZ DB
    Am J Physiol; 1955 Jul; 182(1):155-65. PubMed ID: 13248960
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of systemic blood pressure and vasopressor drugs on coronary blood flow and the electrocardiogram.
    CORDAY E; WILLIAMS JH; DE VERA LB; GOLD H
    Am J Cardiol; 1959 May; 3(5):626-37. PubMed ID: 13649588
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of various vasodilating drugs on vascular lesions due to nicotine sulfate].
    SCALA C
    Riv Patol Clin; 1955 Aug; 10(8):323-46. PubMed ID: 13351421
    [No Abstract]   [Full Text] [Related]  

  • 7. [Functional state of the cardiovascular system in experimental arteriosclerosis].
    Gorev NN; Cherkasskiĭ LP
    Kardiologiia; 1967 Nov; 7(11):37-45. PubMed ID: 5618300
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of vasoactive drugs on the oxygen saturation of coronary sinus blood].
    MERCKER H; LOCHNER W; SCHURMEYER E
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956; 228(1-2):213-5. PubMed ID: 13334628
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of vasoactive drugs on oxygen saturation of coronary sinus blood].
    LOCHNER W; MERCKER H; SCHURMEYER E
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956; 227(4):373-82. PubMed ID: 13334541
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of vasodilators upon the dephosphorylating enzymes of dogs' coronary arteries.
    CARR CJ; BELL FK; BRADYHOUSE MF; KRANTZ JC
    J Pharmacol Exp Ther; 1953 Aug; 108(4):385-92. PubMed ID: 13070159
    [No Abstract]   [Full Text] [Related]  

  • 11. [Demonstration of the efficiency of vasoactive drugs: wish-fulfilment or possibility].
    Schütz RM
    Med Klin; 1976 Sep; 71(39):1594-603. PubMed ID: 790127
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of vasoactive materials on the peripheral blood vessels in the hamster.
    AKERS RP; ZWEIFACH BW
    Am J Physiol; 1955 Dec; 183(3):529-34. PubMed ID: 13283071
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental research on the coronary dilatory action of benzydryl-1-piperonylpiperazine in the intact dog].
    Laubie M; Schmitt H
    Arch Int Pharmacodyn Ther; 1965 May; 155(1):1-6. PubMed ID: 5834935
    [No Abstract]   [Full Text] [Related]  

  • 14. Coronary dilator action. II. Cardiovascular studies on two active compounds, 2-diethylaminoethyl dicyclohexylcarbamate hydrochloride and 2-diethylaminoethyl triphenylmethane-2-carboxylate hydrochloride.
    WINBURY MM; HAMBOURGER WE
    J Pharmacol Exp Ther; 1953 May; 108(1):46-51. PubMed ID: 13053421
    [No Abstract]   [Full Text] [Related]  

  • 15. Basic considerations on the use of pressor drugs.
    Saito T
    Med J Osaka Univ; 1969 Mar; 19(4):309-49. PubMed ID: 4900420
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential vasoconstrictor and vasodilator responses in the proximal and distal human coronary arteries.
    Stupecky GL; Purdy RE
    Proc West Pharmacol Soc; 1988; 31():319-21. PubMed ID: 3211919
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the pharmacology of 2-amino-6-methylheptane-(+)-camphor-10-sulfonate].
    Oelkers HA
    Arzneimittelforschung; 1967 Jan; 17(1):25-8. PubMed ID: 5632522
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prerequisites for the effect of so-called vaso-active agents].
    Horácek J
    Cesk Dermatol; 1972 Feb; 47(1):33-8. PubMed ID: 5011692
    [No Abstract]   [Full Text] [Related]  

  • 19. Coronary vasodilating drugs.
    WILLIS PW; DUFF IF
    Med Clin North Am; 1957 Mar; 41(2):449-69. PubMed ID: 13407229
    [No Abstract]   [Full Text] [Related]  

  • 20. [A pharmacological approach to the problem of the pathology of vascular tonus].
    Votchal BE; Zhmurkin VP
    Klin Med (Mosk); 1968 Oct; 46(10):10-7. PubMed ID: 5717597
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.